文献速递主动脉疾病

瑞典厄勒布鲁大学医院12年全部患者腔内修复破裂腹主动脉瘤经验

A 12-year experience of endovascular repair for ruptured abdominal aortic aneurysms in all patients.
PubMed 文献 · J Vasc Surg · 2022-10-28

该单中心回顾性观察研究纳入2009年10月至2021年9月厄勒布鲁大学医院所有未行既往主动脉手术的破裂腹主动脉瘤患者,均行腔内修复(EVAR),共100例。30天总死亡率为27%(27/100),孤立性肾下型为24%(21/89);1年总死亡率为39%(39/100),孤立性肾下型为37%(33/89)。术前血流动力学不稳定和使用主动脉球囊阻断与30天死亡率增加独立相关。

要点

  • 100例破裂腹主动脉瘤患者全部行EVAR,30天总死亡率27%(27/100),孤立性肾下型24%(21/89)。
  • 1年总死亡率39%(39/100),孤立性肾下型37%(33/89)。
  • 术前血流动力学不稳定和主动脉球囊阻断与30天死亡率增加独立相关。

核心结论

  • 全部100例接受手术的破裂腹主动脉瘤患者均采用EVAR及腔内辅助技术治疗,死亡率相对较低,延续了「仅EVAR」策略。
  • 少数破裂腹主动脉瘤患者被认为不适合手术。
  • 这些发现支持在合适中心将EVAR用于所有破裂腹主动脉瘤的治疗。

研究设计与样本

  • 单中心、回顾性观察性研究,纳入2009年10月至2021年9月厄勒布鲁大学医院所有破裂腹主动脉瘤患者。
  • 排除孤立性髂动脉、胸主动脉和胸腹主动脉破裂,排除既往主动脉开放或腔内干预者,排除接受姑息治疗而非手术干预者。
  • 共100例患者接受EVAR,调查患者特征、围术期和术后数据及死亡率。

主要发现

  • 术前血流动力学不稳定54例(54%),18例(18%)行主动脉球囊阻断。
  • 动脉瘤位于肾下型89例(89%),使用分叉型覆膜支架97例(97%),使用腔内辅助技术27例(27%)。
  • 98例中62例(63%)在局部麻醉下完成EVAR。
  • 30天围术期和术后并发症分别发生于20/100例(20%)和22/79例(28%)。
  • 30天总死亡率27%(27/100),孤立性肾下型24%(21/89);1年总死亡率39%(39/100),孤立性肾下型37%(33/89)。

临床怎么用

  • 作者认为这些发现支持在合适中心将EVAR用于所有破裂腹主动脉瘤的治疗。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular aneurysm repair (EVAR) has been increasingly performed for ruptured abdominal aortic aneurysms (rAAAs). However, multiple randomized trials have failed to demonstrate a survival benefit compared with open aortic surgery. During a 12-year period, 100% of patients without a history of aneurysm surgery had undergone EVAR for a rAAA at Örebro University Hospital, with no emergent open aortic surgery performed. In the present study, we evaluated the mortality and technical success during this "EVAR-only" period. METHODS: A single-center, retrospective observational study was conducted. We identified all patients who had presented to Örebro University Hospital with a rAAA between October 2009 and September 2021. Patients with isolated iliac artery, thoracic, and thoracoabdominal aortic ruptures were not included. Patients who had received previous aortic interventions (open or endovascular) and patients who had received palliative treatment instead of surgical intervention were also excluded. The patient characteristics, perioperative and postoperative data, and mortality rate were investigated. RESULTS: EVAR had been performed in 100 patients. Preoperative hemodynamic instability had been present in 54 patients (54%), and 18 (18%) had undergone aortic balloon occlusion. The aneurysm location was infrarenal in 89 patients (89%). Bifurcated stent grafts had been used in 97 patients (97%), and adjunct endovascular techniques had been used for 27 patients (27%). Of 98 patients, EVAR had been performed with the patient under local anesthesia for 62 patients (63%). Peri- and postoperative complications at 30 days had occurred in 20 of 100 patients (20%) and 22 of 79 patients (28%), respectively. The overall mortality at 30 days was 27% (27 of 100 patients), and the mortality for those with an isolated infrarenal rAAA was 24% (21 of 89 patients). The overall mortality at 1 year was 39% (39 of 100 patients) and for those with an isolated infrarenal rAAA was 37% (33 of 89 patients). The presence of preoperative hemodynamic instability and the use of ABO were statistically significantly and independently associated with increased 30-day mortality on multivariate logistic regression analysis. CONCLUSIONS: All 100 patients who had undergone surgery for a rAAA had been treated using EVAR and endovascular adjuncts, with a relatively low mortality rate, thus continuing the "EVAR-only" approach. A low proportion of rAAA patients were considered surgically unsuitable. These findings support the applicability of EVAR for the treatment of all rAAAs at suitable centers.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. McGreevy DT, Pirouzram A, Djavani Gidlund K, et al. A 12-year experience of endovascular repair for ruptured abdominal aortic aneurysms in all patients. J Vasc Surg. 2022. PMID: 37276170. doi:10.1016/j.jvs.2022.10.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。